Home›Search›Hepatobiliary and Pancreatic Diseases International

Hepatobiliary and Pancreatic Diseases International

Elsevier (Singapore) Pte Ltd · Singapore · Est. 2002

ISSN1499-3872eISSN2352-9377

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.021

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.909

Total Worksi

1,799

Total Citationsi

22,784

2yr Mean Citednessi

1.17

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Hepatobiliary and Pancreatic Diseases International publishes peer-reviewed original papers, reviews, and editorials. The journal is concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionSingapore

Primary LanguageEnglish

1st Year Published2002

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications1,799

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier (Singapore) Pte Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1499-3872 / 2352-9377

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

127

1.6k

2019

138

1.4k

2020

127

1.2k

2021

141

1.3k

2022

119

709

2023

199

2024

100

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

GastroenterologyQ1

HepatologyQ2

Subject Classification

Web of Science Categories

Gastroenterology & Hepatology

Scopus Categories

GastroenterologyHepatology

Research Topics (OpenAlex)

Organ Transplantation Techniques and OutcomesHepatocellular Carcinoma Treatment and PrognosisPancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct DisordersCholangiocarcinoma and Gallbladder Cancer StudiesLiver Disease and TransplantationPancreatitis Pathology and TreatmentLiver Disease Diagnosis and TreatmentPediatric Hepatobiliary Diseases and TreatmentsLiver physiology and pathology

Frequently asked questions about Hepatobiliary and Pancreatic Diseases International

Is Hepatobiliary and Pancreatic Diseases International a predatory journal?

PubScope has no integrity flags on record for Hepatobiliary and Pancreatic Diseases International: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Hepatobiliary and Pancreatic Diseases International?

Hepatobiliary and Pancreatic Diseases International is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.17.

Is Hepatobiliary and Pancreatic Diseases International indexed in Scopus and Web of Science?

Hepatobiliary and Pancreatic Diseases International is indexed in Web of Science, Scopus.